Gossamer Bio, Inc.
GOSS
$1.45
$0.1511.54%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -90.11% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -90.11% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -90.11% | -- | |||
| SG&A Expenses | -1.93% | -9.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.81% | 4.28% | |||
| Operating Income | -165.12% | 224.14% | |||
| Income Before Tax | -159.51% | 228.00% | |||
| Income Tax Expenses | -125.52% | -- | |||
| Earnings from Continuing Operations | -162.57% | 217.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -162.57% | 217.42% | |||
| EBIT | -165.12% | 224.14% | |||
| EBITDA | -164.40% | 225.51% | |||
| EPS Basic | -162.55% | 217.18% | |||
| Normalized Basic EPS | -159.47% | 219.12% | |||
| EPS Diluted | -162.75% | 214.16% | |||
| Normalized Diluted EPS | -162.73% | 212.93% | |||
| Average Basic Shares Outstanding | 0.06% | 0.22% | |||
| Average Diluted Shares Outstanding | -5.11% | 5.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
